CN Stock MarketDetailed Quotes

Tianjin Lisheng Pharmaceutical (002393)

Watchlist
  • 22.04
  • -0.08-0.36%
Market Closed Jan 16 15:00 CST
5.68BMarket Cap14.71P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tianjin Lisheng Pharmaceutical (002393) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
Total operating revenue
-1.61%1.01B
-1.76%731.51M
1.37%369.84M
15.88%1.34B
12.31%1.02B
13.25%744.64M
8.71%364.85M
0.56%1.15B
1.06%911.57M
6.95%657.49M
Operating revenue
-1.61%1.01B
-1.76%731.51M
1.37%369.84M
15.88%1.34B
12.31%1.02B
13.25%744.64M
8.71%364.85M
0.56%1.15B
1.06%911.57M
6.95%657.49M
Other operating revenue
----
-86.61%475.86K
----
-47.94%4.01M
----
76.95%3.55M
----
27.25%7.7M
----
-23.81%2.01M
Total operating cost
-3.55%871.04M
-1.66%619.76M
-1.13%305.79M
24.96%1.21B
18.71%903.12M
11.77%630.23M
7.78%309.28M
-3.00%969.53M
-1.25%760.76M
5.88%563.85M
Operating cost
-7.34%424.87M
-8.48%298.78M
-9.79%155.28M
28.24%600.36M
29.98%458.5M
30.83%326.45M
30.87%172.14M
-3.73%468.15M
-3.67%352.76M
2.57%249.52M
Operating tax surcharges
-5.58%16.81M
-9.04%11.66M
-6.68%5.66M
2.17%23.37M
3.10%17.8M
6.84%12.82M
11.24%6.06M
-5.13%22.87M
-2.80%17.27M
-2.51%12M
Operating expense
-1.63%280.14M
4.91%222.72M
14.02%109.95M
15.09%367.08M
4.25%284.79M
6.79%212.3M
-4.68%96.43M
-5.08%318.94M
-1.83%273.17M
6.73%198.8M
Administration expense
18.56%105.31M
16.94%71.44M
21.23%33.38M
21.26%137.76M
15.12%88.83M
9.82%61.1M
1.23%27.54M
-0.74%113.61M
-2.87%77.16M
10.36%55.63M
Financial expense
-14.10%-46.4M
-20.81%-44.84M
-67.21%-29.23M
26.93%-43.59M
-9.31%-40.66M
-109.13%-37.12M
-653.75%-17.48M
11.43%-59.66M
38.22%-37.2M
26.90%-17.75M
-Interest expense (Financial expense)
13.01%1.91M
-25.53%1.28M
-61.00%359.61K
256.04%2.66M
244.75%1.69M
360.09%1.72M
616.85%922.02K
-14.78%745.83K
-16.04%490.57K
-14.68%374.92K
-Interest Income (Financial expense)
-13.25%-49.09M
-19.68%-46.67M
-61.44%-29.72M
22.13%-47.13M
-14.75%-43.35M
-114.07%-38.99M
-632.56%-18.41M
11.32%-60.53M
37.93%-37.78M
26.57%-18.22M
Research and development
-3.79%90.3M
9.70%59.99M
25.08%30.75M
19.81%126.54M
20.96%93.86M
-16.70%54.69M
2.74%24.58M
-0.33%105.62M
-12.77%77.6M
1.70%65.65M
Credit Impairment Loss
950.05%294.76K
526.01%147.72K
----
-93.31%175.06K
-111.35%-34.68K
-121.43%-34.68K
-67.70%25.07K
216.03%2.62M
1,282.87%305.48K
726.66%161.84K
Asset Impairment Loss
-7,104.81%-16.44M
---16.44M
----
47.86%-15.25M
---228.11K
----
--0
-48.97%-29.25M
----
----
Other net revenue
283.59%309.76M
4,662.39%302.23M
-65.18%3.17M
-58.94%97.02M
-68.07%80.75M
-43.83%6.35M
40.77%9.1M
913.65%236.31M
3,325.14%252.91M
76.21%11.3M
Fair value change income
83.51%2.4M
-117.65%-197.79K
--1.01M
366.41%2.9M
--1.31M
--1.12M
----
122.02%621.77K
----
----
Invest income
316.03%319.54M
10,361.53%315.67M
-86.68%1.09M
546.17%100.18M
535.44%76.81M
-71.43%3.02M
32.69%8.2M
-34.54%15.5M
49.54%12.09M
85.18%10.56M
-Including: Investment income associates
----
----
----
----
711.03%70.23M
----
81.51%6.48M
6.19%11.02M
23.10%8.66M
49.07%7.34M
Asset deal income
--282.63K
--364.7K
---50.31K
-100.04%-95.58K
--0
----
--0
785.53%238.7M
--238.61M
--14.74K
Other revenue
26.80%3.68M
19.42%2.68M
28.35%1.12M
12.34%9.11M
52.01%2.9M
300.07%2.24M
357.53%873.27K
118.82%8.11M
16.61%1.91M
-23.68%560.61K
Operating profit
121.44%446M
242.83%413.98M
3.93%67.22M
-47.20%221.65M
-50.11%201.41M
15.07%120.75M
17.35%64.67M
255.57%419.81M
190.49%403.73M
18.40%104.94M
Add:Non operating Income
-6.04%1.55M
202.36%1.36M
22.81%159.54K
10.69%620.89K
22.25%1.65M
-62.42%449.97K
-88.51%129.91K
59.40%560.9K
192.71%1.35M
163.15%1.2M
Less:Non operating expense
1,308.17%14.54M
2,369.28%13.9M
-7.07%15.86K
4,052.69%6.32M
865.55%1.03M
453.51%562.79K
931.90%17.06K
193.06%152.26K
5,082.02%106.94K
4,826.96%101.68K
Total profit
114.33%433.01M
232.76%401.45M
3.98%67.36M
-48.61%215.95M
-50.11%202.03M
13.78%120.64M
15.20%64.78M
255.02%420.21M
190.43%404.97M
19.03%106.03M
Less:Income tax cost
74.30%58.73M
189.83%56.11M
21.11%10.79M
-48.64%29.99M
-45.92%33.69M
22.13%19.36M
-8.51%8.91M
135.83%58.39M
132.33%62.31M
-7.46%15.85M
Net profit
122.35%374.28M
240.97%345.34M
1.24%56.57M
-48.61%185.96M
-50.88%168.33M
12.31%101.28M
20.16%55.88M
286.54%361.83M
204.26%342.67M
25.33%90.18M
Net profit from continuing operation
122.35%374.28M
240.97%345.34M
1.24%56.57M
-48.61%185.96M
-50.88%168.33M
12.31%101.28M
20.16%55.88M
286.54%361.83M
204.26%342.67M
25.33%90.18M
Less:Minority Profit
486.13%3.54M
324.80%2.41M
139.50%1.3M
--1.43M
---917.97K
---1.07M
---3.28M
----
----
----
Net profit of parent company owners
119.05%370.74M
235.04%342.92M
-6.56%55.28M
-49.00%184.53M
-50.61%169.25M
13.50%102.35M
27.22%59.16M
286.54%361.83M
204.26%342.67M
25.33%90.18M
Earning per share
Basic earning per share
118.18%1.44
232.50%1.33
-8.70%0.21
-48.57%0.72
-50.38%0.66
14.29%0.4
-8.00%0.23
174.51%1.4
114.52%1.33
-10.26%0.35
Diluted earning per share
118.18%1.44
232.50%1.33
-8.70%0.21
-48.57%0.72
-50.38%0.66
14.29%0.4
-8.00%0.23
174.51%1.4
114.52%1.33
-10.26%0.35
Other composite income
-173.21%-174.73M
329.93%238.67M
Other composite income of parent company owners
----
----
----
-173.21%-174.73M
----
----
----
329.93%238.67M
----
----
Total composite income
122.35%374.28M
240.97%345.34M
1.24%56.57M
-98.13%11.23M
-50.88%168.33M
12.31%101.28M
20.16%55.88M
5,992.10%600.49M
204.26%342.67M
25.33%90.18M
Total composite income of parent company owners
122.35%374.28M
235.04%342.92M
-6.56%55.28M
-98.37%9.8M
-50.88%168.33M
13.50%102.35M
27.22%59.16M
5,992.10%600.49M
204.26%342.67M
25.33%90.18M
Total composite income of minority owners
----
324.80%2.41M
139.50%1.3M
--1.43M
----
---1.07M
---3.28M
----
----
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Xinyong Zhonghe Certified Public Accountants (Special General Partnership)
--
--
--
Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)
--
--
(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023
Total operating revenue -1.61%1.01B-1.76%731.51M1.37%369.84M15.88%1.34B12.31%1.02B13.25%744.64M8.71%364.85M0.56%1.15B1.06%911.57M6.95%657.49M
Operating revenue -1.61%1.01B-1.76%731.51M1.37%369.84M15.88%1.34B12.31%1.02B13.25%744.64M8.71%364.85M0.56%1.15B1.06%911.57M6.95%657.49M
Other operating revenue -----86.61%475.86K-----47.94%4.01M----76.95%3.55M----27.25%7.7M-----23.81%2.01M
Total operating cost -3.55%871.04M-1.66%619.76M-1.13%305.79M24.96%1.21B18.71%903.12M11.77%630.23M7.78%309.28M-3.00%969.53M-1.25%760.76M5.88%563.85M
Operating cost -7.34%424.87M-8.48%298.78M-9.79%155.28M28.24%600.36M29.98%458.5M30.83%326.45M30.87%172.14M-3.73%468.15M-3.67%352.76M2.57%249.52M
Operating tax surcharges -5.58%16.81M-9.04%11.66M-6.68%5.66M2.17%23.37M3.10%17.8M6.84%12.82M11.24%6.06M-5.13%22.87M-2.80%17.27M-2.51%12M
Operating expense -1.63%280.14M4.91%222.72M14.02%109.95M15.09%367.08M4.25%284.79M6.79%212.3M-4.68%96.43M-5.08%318.94M-1.83%273.17M6.73%198.8M
Administration expense 18.56%105.31M16.94%71.44M21.23%33.38M21.26%137.76M15.12%88.83M9.82%61.1M1.23%27.54M-0.74%113.61M-2.87%77.16M10.36%55.63M
Financial expense -14.10%-46.4M-20.81%-44.84M-67.21%-29.23M26.93%-43.59M-9.31%-40.66M-109.13%-37.12M-653.75%-17.48M11.43%-59.66M38.22%-37.2M26.90%-17.75M
-Interest expense (Financial expense) 13.01%1.91M-25.53%1.28M-61.00%359.61K256.04%2.66M244.75%1.69M360.09%1.72M616.85%922.02K-14.78%745.83K-16.04%490.57K-14.68%374.92K
-Interest Income (Financial expense) -13.25%-49.09M-19.68%-46.67M-61.44%-29.72M22.13%-47.13M-14.75%-43.35M-114.07%-38.99M-632.56%-18.41M11.32%-60.53M37.93%-37.78M26.57%-18.22M
Research and development -3.79%90.3M9.70%59.99M25.08%30.75M19.81%126.54M20.96%93.86M-16.70%54.69M2.74%24.58M-0.33%105.62M-12.77%77.6M1.70%65.65M
Credit Impairment Loss 950.05%294.76K526.01%147.72K-----93.31%175.06K-111.35%-34.68K-121.43%-34.68K-67.70%25.07K216.03%2.62M1,282.87%305.48K726.66%161.84K
Asset Impairment Loss -7,104.81%-16.44M---16.44M----47.86%-15.25M---228.11K------0-48.97%-29.25M--------
Other net revenue 283.59%309.76M4,662.39%302.23M-65.18%3.17M-58.94%97.02M-68.07%80.75M-43.83%6.35M40.77%9.1M913.65%236.31M3,325.14%252.91M76.21%11.3M
Fair value change income 83.51%2.4M-117.65%-197.79K--1.01M366.41%2.9M--1.31M--1.12M----122.02%621.77K--------
Invest income 316.03%319.54M10,361.53%315.67M-86.68%1.09M546.17%100.18M535.44%76.81M-71.43%3.02M32.69%8.2M-34.54%15.5M49.54%12.09M85.18%10.56M
-Including: Investment income associates ----------------711.03%70.23M----81.51%6.48M6.19%11.02M23.10%8.66M49.07%7.34M
Asset deal income --282.63K--364.7K---50.31K-100.04%-95.58K--0------0785.53%238.7M--238.61M--14.74K
Other revenue 26.80%3.68M19.42%2.68M28.35%1.12M12.34%9.11M52.01%2.9M300.07%2.24M357.53%873.27K118.82%8.11M16.61%1.91M-23.68%560.61K
Operating profit 121.44%446M242.83%413.98M3.93%67.22M-47.20%221.65M-50.11%201.41M15.07%120.75M17.35%64.67M255.57%419.81M190.49%403.73M18.40%104.94M
Add:Non operating Income -6.04%1.55M202.36%1.36M22.81%159.54K10.69%620.89K22.25%1.65M-62.42%449.97K-88.51%129.91K59.40%560.9K192.71%1.35M163.15%1.2M
Less:Non operating expense 1,308.17%14.54M2,369.28%13.9M-7.07%15.86K4,052.69%6.32M865.55%1.03M453.51%562.79K931.90%17.06K193.06%152.26K5,082.02%106.94K4,826.96%101.68K
Total profit 114.33%433.01M232.76%401.45M3.98%67.36M-48.61%215.95M-50.11%202.03M13.78%120.64M15.20%64.78M255.02%420.21M190.43%404.97M19.03%106.03M
Less:Income tax cost 74.30%58.73M189.83%56.11M21.11%10.79M-48.64%29.99M-45.92%33.69M22.13%19.36M-8.51%8.91M135.83%58.39M132.33%62.31M-7.46%15.85M
Net profit 122.35%374.28M240.97%345.34M1.24%56.57M-48.61%185.96M-50.88%168.33M12.31%101.28M20.16%55.88M286.54%361.83M204.26%342.67M25.33%90.18M
Net profit from continuing operation 122.35%374.28M240.97%345.34M1.24%56.57M-48.61%185.96M-50.88%168.33M12.31%101.28M20.16%55.88M286.54%361.83M204.26%342.67M25.33%90.18M
Less:Minority Profit 486.13%3.54M324.80%2.41M139.50%1.3M--1.43M---917.97K---1.07M---3.28M------------
Net profit of parent company owners 119.05%370.74M235.04%342.92M-6.56%55.28M-49.00%184.53M-50.61%169.25M13.50%102.35M27.22%59.16M286.54%361.83M204.26%342.67M25.33%90.18M
Earning per share
Basic earning per share 118.18%1.44232.50%1.33-8.70%0.21-48.57%0.72-50.38%0.6614.29%0.4-8.00%0.23174.51%1.4114.52%1.33-10.26%0.35
Diluted earning per share 118.18%1.44232.50%1.33-8.70%0.21-48.57%0.72-50.38%0.6614.29%0.4-8.00%0.23174.51%1.4114.52%1.33-10.26%0.35
Other composite income -173.21%-174.73M329.93%238.67M
Other composite income of parent company owners -------------173.21%-174.73M------------329.93%238.67M--------
Total composite income 122.35%374.28M240.97%345.34M1.24%56.57M-98.13%11.23M-50.88%168.33M12.31%101.28M20.16%55.88M5,992.10%600.49M204.26%342.67M25.33%90.18M
Total composite income of parent company owners 122.35%374.28M235.04%342.92M-6.56%55.28M-98.37%9.8M-50.88%168.33M13.50%102.35M27.22%59.16M5,992.10%600.49M204.26%342.67M25.33%90.18M
Total composite income of minority owners ----324.80%2.41M139.50%1.3M--1.43M-------1.07M---3.28M------------
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Xinyong Zhonghe Certified Public Accountants (Special General Partnership)------Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.85%
Sample Name
Sample Code
 +16.38%
Sample Name
Sample Code
 +13.45%
4
BIDU-SW
09888
+5.97%
5
JD HEALTH
06618
+5.25%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.11%
Sample Name
Sample Code
 +2.53%
Sample Name
Sample Code
 +2.08%
4
Tempus AI
TEM
+2.05%
5
Block
XYZ
+1.59%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -